Market Overview

Retinitis Pigmentosa | A Pipeline Analysis Report 2018 | Technavio

Share:

Technavio has announced their latest pipeline analysis report on the retinitis
pigmentosa market
. The report includes a detailed analysis of
the pipeline molecules under investigation within the defined data
collection period to treat retinitis pigmentosa.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180720005420/en/

Technavio has published a new report on the drug development pipeline for retinitis pigmentosa, incl ...

Technavio has published a new report on the drug development pipeline for retinitis pigmentosa, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Retinitis pigmentosa: Market overview

Retinitis pigmentosa is a genetic disorder that results in vision loss.
It is known to progress over a period and results in complete blindness.
Retinitis pigmentosa is caused by mutations in one of over 100 types of
genes. The breakdown and loss of cells in the retina are also known to
cause retinitis pigmentosa. Retinitis pigmentosa can broadly be
classified into three categories, namely nonsyndromic, syndromic, and
secondary. Nonsyndromic is when the disease occurs alone and does not
affect any other sensory organs. Syndromic occurs when retinitis
pigmentosa occurs with other neurosensory disorders or developmental
abnormalities. Secondary occurs because of other systemic diseases.

According to a senior market research analyst at Technavio, "Retinitis
pigmentosa is one of the most common types of inherited retinal
disorders. The prevalence of the disorder is higher in children and
young adults compared to the older population. Patients with retinitis
pigmentosa generally inherit this disease from their parents. The onset
is often in childhood. However, in some cases, the disease does not
begin until adulthood. The type and speed of vision loss caused by
retinitis pigmentosa differ from person to person and factors, such as
the form of the condition."

Retinitis pigmentosa: Segmentation analysis

This pipeline analysis report segments the retinitis pigmentosa market
based on therapies employed (monotherapy), RoA (subretinal,
intravitreal, implant, intraocular, and topical), therapeutic modality
(gene, stem cell, protein and recombinant fusion protein), targets
(RPGR, RPE65, and RLBP1), MoA (gene therapy, stem cell therapy,
apoptosis inhibitors, VEGF inhibitor, Nerve growth factor receptor
agonists, and cellular growth stimulator), geographical segmentation
(US, UK, and France) and recruitment status (recruiting, active,not
recruiting, not yet recruiting, and completed). It provides an in-depth
analysis of the prominent factors influencing the market, including
drivers, opportunities, trends, and industry-specific challenges.

Around 61% of the molecules that are being investigated for the
treatment of retinitis pigmentosa are gene therapy.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!